NCT07021742
BioHealx® Anal Fistula Device Post Market Surveillance Study
At risk: Primary completion moved at least 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 24 words
- Primary completion pushed from Oct 2026 to Feb 2027
- Study completion pushed from Dec 2026 to Mar 2027
- Secondary endpoints: details revised at 5 of 5 entries
- Minor Study sites: 5 to 6v5
- Minor Study sites: 2 to 5v4
- Minor Study sites: 1 to 2v3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Jun 2025 to Jun 14, 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Successful Closure Repair
Timeframe: 12 Months
Non-Recurrence Incidence
Timeframe: 24 and 36 Months
Secondary (5)
Fecal Incontinence Quality of Life
Fecal Incontinence Severity Index (FISI)
Health Related Quality of Life
Pain Score
Rescue Analgesic and Therapeutic Antibiotic Use
Arms and interventions
BioHealx
Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device.
Devices: BioHealx
Sites
6 sites in 1 country